Company

MediWound Ltd.

Headquarters: Yavne, Israel

Employees: 75

NASDAQ: MDWD -1.83%

Market Cap

$182.0 Million

USD as of July 1, 2024

Market Cap History

MediWound Ltd. market capitalization over time

Evolution of MediWound Ltd. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of MediWound Ltd.

Detailed Description

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

MediWound Ltd. has the following listings and related stock indices.


Stock: NASDAQ: MDWD wb_incandescent

Stock: FSX: M8W wb_incandescent

Details

Headquarters:

42 Hayarkon Street

Yavne, 8122745

Israel

Phone: 972 7 797 14100

Fax: 972 7 797 14111